Tortoise Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7K | Hold |
845
| – | – | ﹤0.01% | 452 |
|
|
2025
Q1 | $30.6K | Hold |
845
| – | – | ﹤0.01% | 439 |
|
|
2024
Q4 | $35.5K | Hold |
845
| – | – | ﹤0.01% | 476 |
|
|
2024
Q3 | $46.9K | Hold |
845
| – | – | ﹤0.01% | 416 |
|
|
2024
Q2 | $34.7K | Hold |
845
| – | – | ﹤0.01% | 445 |
|
|
2024
Q1 | $39.5K | Hold |
845
| – | – | ﹤0.01% | 409 |
|
|
2023
Q4 | $40.4K | Hold |
845
| – | – | 0.01% | 386 |
|
|
2023
Q3 | $30.1K | Hold |
845
| – | – | ﹤0.01% | 414 |
|
|
2023
Q2 | $39K | Hold |
845
| – | – | 0.01% | 369 |
|
|
2023
Q1 | $33.9K | Hold |
845
| – | – | 0.01% | 382 |
|
|
2022
Q4 | $39.1K | Hold |
845
| – | – | 0.01% | 353 |
|
|
2022
Q3 | $35K | Hold |
845
| – | – | 0.01% | 361 |
|
|
2022
Q2 | $50K | Hold |
845
| – | – | 0.01% | 302 |
|
|
2022
Q1 | $61K | Hold |
845
| – | – | 0.01% | 282 |
|
|
2021
Q4 | $71K | Hold |
845
| – | – | 0.01% | 255 |
|
|
2021
Q3 | $76K | Hold |
845
| – | – | 0.02% | 227 |
|
|
2021
Q2 | $81K | Sell |
845
-100
| -11% | -$9.59K | 0.02% | 214 |
|
|
2021
Q1 | $108K | Hold |
945
| – | – | 0.02% | 194 |
|
|
2020
Q4 | $131K | Sell |
945
-100
| -10% | -$13.9K | 0.03% | 174 |
|
|
2020
Q3 | $86K | Hold |
1,045
| – | – | 0.02% | 191 |
|
|
2020
Q2 | $82K | Hold |
1,045
| – | – | 0.02% | 189 |
|
|
2020
Q1 | $46K | Hold |
1,045
| – | – | 0.01% | 225 |
|
|
2019
Q4 | $45K | Hold |
1,045
| – | – | 0.01% | 253 |
|
|
2019
Q3 | $45K | Hold |
1,045
| – | – | 0.01% | 245 |
|
|
2019
Q2 | $66K | Hold |
1,045
| – | – | 0.02% | 223 |
|
|
2019
Q1 | $72K | Hold |
1,045
| – | – | 0.02% | 215 |
|
|
2018
Q4 | $45K | Hold |
1,045
| – | – | 0.01% | 245 |
|
|
2018
Q3 | $80K | Hold |
1,045
| – | – | 0.02% | 202 |
|
|
2018
Q2 | $80K | Hold |
1,045
| – | – | 0.02% | 203 |
|
|
2018
Q1 | $53K | Hold |
1,045
| – | – | 0.01% | 235 |
|
|
2017
Q4 | $48K | Hold |
1,045
| – | – | 0.01% | 251 |
|
|
2017
Q3 | $56K | Hold |
1,045
| – | – | 0.02% | 214 |
|
|
2017
Q2 | $65K | Buy |
1,045
+100
| +11% | +$6.22K | 0.02% | 190 |
|
|
2017
Q1 | $64K | Sell |
945
-150
| -14% | -$10.2K | 0.02% | 181 |
|
|
2016
Q4 | $77K | Hold |
1,095
| – | – | 0.03% | 167 |
|
|
2016
Q3 | $78K | Hold |
1,095
| – | – | 0.03% | 157 |
|
|
2016
Q2 | $54K | Hold |
1,095
| – | – | 0.02% | 192 |
|
|
2016
Q1 | $69K | Buy |
1,095
+150
| +16% | +$9.45K | 0.02% | 170 |
|
|
2015
Q4 | $106K | Hold |
945
| – | – | 0.04% | 140 |
|
|
2015
Q3 | $91K | Sell |
945
-230
| -20% | -$22.1K | 0.03% | 158 |
|
|
2015
Q2 | $120K | Sell |
1,175
-553
| -32% | -$56.5K | 0.05% | 142 |
|
|
2015
Q1 | $107K | Hold |
1,728
| – | – | 0.04% | 150 |
|
|
2014
Q4 | $76K | Hold |
1,728
| – | – | 0.03% | 182 |
|
|
2014
Q3 | $98K | Buy |
+1,728
| New | +$98K | 0.04% | 152 |
|